Published in Ann Surg Treat Res on February 27, 2015
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J (1979) 8.95
Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther (2000) 5.09
Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol (2003) 3.15
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum (2007) 3.02
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med (2005) 2.25
Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem (2002) 1.92
Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology (1999) 1.71
Polarization microscopic studies of connective tissue stained with picro-sirius red FBA. Beitr Pathol (1973) 1.62
Imatinib attenuates diabetes-associated atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 1.59
Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol (2006) 1.41
Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate. Circ Res (2006) 1.24
Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation (1993) 1.22
Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent? J Biol Chem (2006) 1.16
Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol (2006) 1.14
The biology of restenosis. Prog Cardiovasc Dis (1997) 1.12
Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J Dermatol Sci (2000) 1.11
Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis (2004) 1.11
Constitutively active glycogen synthase kinase-3beta gene transfer sustains apoptosis, inhibits proliferation of vascular smooth muscle cells, and reduces neointima formation after balloon injury in rats. Arterioscler Thromb Vasc Biol (2003) 0.98
Induction of vascular atrophy as a novel approach to treating restenosis. A review. J Vasc Surg (2007) 0.92
The essential role of p21 in radiation-induced cell cycle arrest of vascular smooth muscle cell. J Mol Cell Cardiol (2004) 0.88
On the ability of imatinib mesylate to inhibit smooth muscle cell proliferation without delaying endothelialization: an in vitro study. Vascul Pharmacol (2009) 0.85
Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor. Circulation (1999) 0.85
Synergistic suppression of rat neointimal hyperplasia by rapamycin and imatinib mesylate: implications for the prevention of accelerated arteriosclerosis. J Vasc Res (2006) 0.81
Expression of coxsackievirus and adenovirus receptor in neointima of the rat carotid artery. Cardiovasc Pathol (2004) 0.81
Angiographic regression of cardiac allograft vasculopathy after introducing sirolimus immunosuppression. J Heart Lung Transplant (2003) 0.81
Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans. Int J Cardiol (2007) 0.77
Tolerance-inducing strategies in transplantation surgery-current status and perspectives. Langenbecks Arch Surg (2003) 0.77
Current strategy for the treatment of symptomatic spontaneous isolated dissection of superior mesenteric artery. J Vasc Surg (2011) 1.79
Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort. PLoS One (2017) 1.39
Induction of vascular atrophy as a novel approach to treating restenosis. A review. J Vasc Surg (2007) 0.92
Role of three-dimensional computed tomography venography as a powerful navigator for varicose vein surgery. J Vasc Surg (2010) 0.91
Therapeutic equivalence and pharmacokinetics of generic tacrolimus formulation in de novo kidney transplant patients. Nephrol Dial Transplant (2013) 0.85
Infected Aortic Aneurysm caused by Mycobacterium bovis after Intravesical Bacillus Calmette-Guérin Treatment for Bladder Cancer. Infect Chemother (2015) 0.84
Surgical Treatment of Infected Aortoiliac Aneurysm. Vasc Specialist Int (2015) 0.82
Serum bilirubin affects graft outcomes through UDP-glucuronosyltransferase sequence variation in kidney transplantation. PLoS One (2014) 0.82
Clinical significance of type I endoleak on completion angiography. Ann Surg Treat Res (2014) 0.81
CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients. Transplantation (2010) 0.81
Anatomical Features and Early Outcomes of Endovascular Repair of Abdominal Aortic Aneurysm from a Korean Multicenter Registry. Vasc Specialist Int (2015) 0.79
Chronic allograft injury by subclinical borderline change: evidence from serial protocol biopsies in kidney transplantation. J Korean Surg Soc (2012) 0.79
Inhibition of intimal hyperplasia by local perivascular application of rapamycin and imatinib mesilate after carotid balloon injury. J Korean Surg Soc (2013) 0.78
Longitudinal Evaluation of Segmental Arterial Mediolysis in Splanchnic Arteries: Case Series and Systematic Review. PLoS One (2016) 0.78
Cyclosporine Sparing Effect of Enteric-Coated Mycophenolate Sodium in De Novo Kidney Transplantation. Yonsei Med J (2017) 0.75
Intimal hyperplasia in loop-injured carotid arteries is attenuated in transglutaminase 2-null mice. J Korean Med Sci (2014) 0.75
Delayed Presentation of Endovenous Heat-Induced Thrombosis Treated by Thrombolysis and Subsequent Open Thrombectomy. Vasc Specialist Int (2016) 0.75
Open Surgical Repair of Abdominal Aortic Aneurysm Coexisting with Horseshoe Kidney. Vasc Specialist Int (2015) 0.75
Follow-up results of acute portal and splenic vein thrombosis with or without anticoagulation therapy after hepatobiliary and pancreatic surgery. Ann Surg Treat Res (2015) 0.75
Outcomes of Arteriovenous Fistula for Hemodialysis in Pediatric and Adolescent Patients. Vasc Specialist Int (2016) 0.75
The Need for New Donor Stratification to Predict Graft Survival in Deceased Donor Kidney Transplantation. Yonsei Med J (2017) 0.75
Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants. Kidney Res Clin Pract (2012) 0.75
Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function. PLoS One (2016) 0.75
Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines. Vasc Specialist Int (2016) 0.75
Pre-clinical results in pig-to-non-human primate islet xenotransplantation using anti-CD40 antibody (2C10R4)-based immunosuppression. Xenotransplantation (2017) 0.75
Outcome after early thrombotic occlusion of arteriovenous fistulas. J Vasc Access (2022) 0.75
Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation. J Korean Med Sci (2018) 0.75